Navigation Links
Amifostine Renders Cancer More Susceptible To Radiation

The drug amifostine has been found to ease most of the side affects associated with radiation therapy and also make cancer more susceptible to radiation, according to doctors in Brazil. Their findings are published in the March 1// issue of the International Journal of Radiation

Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology. The reserachers decided to check out data from already published studies to evaluate if adding amifostine to radiation therapy decreased the occurrence of side effects like difficulty in swallowing, dry mouth, lung inflammation, bladder inflammation, problems with the esophagus and inflammation of the mucous membranes. Sometimes these side effects cause significant problems and even force the treatment to be stopped while the patient recovers. The study also wanted to find out if amifostine protected the cancer from radiation. The researchers evaluated the effects of amifostine in 14 randomized, controlled trials in which 1,451 patients were enrolled. These patients were split into two groups, one receiving radiation alone, while the other received radiation as well as amifostine. It was found that contrary to fears, amifostine rendered the tumor more susceptible to radiation and patients on amifostine were more likely to have their cancer completely cured by radiation. But amifostine did have some side effects like nausea and vomiting. "Our research shows that adding amifostine to radiation therapy helps reduce side effects while at the same time making the radiation treatments more effective at killing the cancer cells," said Andre Deeke Sasse, M.D., a radiation oncologist at Nucleo Brasileiro de Oncologia Baseada em Evidencias in Sao Paolo, Brazil. "We recommend that patients undergoing radiation therapy for cancer ask their doctor about adding amifostine to their treatment." For more information on radiation therapy for cancer, please visit www.rtanswers.org. Contact: Nick Lashinsky nickl@astro.org 703-227-0185 American Society for Therapeutic Radiology and Oncology Source: Eurekalert
'"/>




Related medicine news :

1. Anthrax Spores: Animal Skins on Drums, Renders Vado Diomande, Sick
2. Fibroids unlikely to Turn Cancerous
3. Virus Level could Predict Cervical Cancer Risk
4. Cancer Doctors Okays Controversial Prostate Therapy
5. Potential New Cancer Gene Identified
6. Consensus on "Combination Therapy" for Breast Cancer
7. Cancers of Colon & Rectum linked to Cigarette Smoking
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. The Cancer Rumour mill working over time
10. Cancer drugs in development nearly doubled since 1995
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)...  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas ...
(Date:6/23/2016)... June 23, 2016  Experian Health, the ... transforming the patient payment and care experience, ... new products and services that will enhance ... cycle offerings. These award-winning solutions will enable ... remain compliant in an ever-changing environment and ...
Breaking Medicine Technology: